Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Topics
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Co-Founder Trims His Position in GitLab in $2.4 Million Sale ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers GTLB
Exposures Legal Regulatory
News headline image
Deadline to Lead in Securities Class Action Against Driven Brands Holdings Inc. (NASDAQ: DRVN) is May 8, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Tickers DRVN
Exposures Financial Legal Regulatory
News headline image
Deadline to Lead in Securities Class Action Against Driven Brands Holdings Inc. (NASDAQ: DRVN) is May 8, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit Regulatory Compliance
Tickers DRVN
Exposures Financial Legal Regulatory
News headline image
COO Trims 25,949 Shares of Global-E Online: What to Know ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers GLBE
Exposures Legal Regulatory
News headline image
North of South Dumps $38.5 Million Vipshop Stake -- What Investors Should Know ↗
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
Tickers IBN JD TSM VIPS YMM YPF
Exposures Legal Regulatory Supply Chain
News headline image
Centennial Wealth Advisory Builds Stake in First Trust Growth Strength ETF, According to Recent SEC Filing ↗
Via The Motley Fool
Topics ETFs Regulatory Compliance
Tickers FTGS
Exposures Legal Regulatory
News headline image
Remitly Exec Sells $650K in Shares Amid Record Profitability, but Here's What Investors Should Actually Be Watching ↗
Via The Motley Fool
Topics Derivatives Regulatory Compliance
Tickers RELY
Exposures Derivatives Legal Regulatory
News headline image
Is VRIG Worth a Look? Auour Investments Thinks So, Initiating a $7.4 Million Stake ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
Tickers IVZ VRIG
Exposures Debt Markets Legal Regulatory
News headline image
Travere Therapeutics Director Trims Stake Amid 168% Run, But Is FILSPARI's Revenue Story Just Getting Started? ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers TVTX
Exposures Legal Regulatory
News headline image
Insider Sells 10,000 Shares as Photronics Posts $225 Million Quarter ↗
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
Tickers PLAB
Exposures Legal Regulatory Supply Chain
InvestorNewsBreaks – Channelchek by Noble Highlights Enhanced Group Inc.’s Planned SPAC Merger with A Paradise Acquisition Corp. (NASDAQ: APAD) Amid Evolving Market Dynamics
Via Investor Brand Network
Topics Regulatory Compliance
Tickers APAD
Exposures Legal Regulatory
News headline image
Is Keudell/Morrison's $3.4 Million Trim of FLXR a Signal -- or Just Smart Rebalancing? ↗
Via The Motley Fool
Topics ETFs Regulatory Compliance
Tickers FLXR VWOB
Exposures Legal Regulatory
News headline image
Vita Coco's CEO Sold Company Shares Worth $1.25 Million. Here's What That Means for Investors. ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers COCO
Exposures Legal Regulatory
News headline image
Wealth Manager Builds Position in Fixed-Income ETF, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
Tickers AAPL DFGP VCSH
Exposures Debt Markets Legal Regulatory
News headline image
Nvidia Chipmaking Rival and AI Startup Cerebras Systems Files for IPO ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
Tickers AMZN NVDA
Exposures Artificial Intelligence Legal Regulatory
News headline image
A Revolve Group (RVLV) Co-CEO Sold 16,000 Shares for $414,000 ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers RVLV
Exposures Legal Regulatory
News headline image
An Alignment Healthcare (ALHC) Insider Sold 30,000 Shares for $626,000 ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers ALHC
Exposures Legal Regulatory
News headline image
Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers ADPT
Exposures COVID-19 Legal Regulatory
News headline image
Prediction: The Cryptocurrency XRP Will Be Worth Less Than $1 in 5 Years ↗
Via The Motley Fool
Topics ETFs Lawsuit Regulatory Compliance
Tickers XRPC
Exposures Financial Legal Regulatory
News headline image
What's the Best Bitcoin ETF to Buy in 2026? ↗
Via The Motley Fool
Topics ETFs Regulatory Compliance
Tickers BLK FIS GS IBIT MS MSBT
Exposures Legal Regulatory
News headline image
Q4 Diversified Financial Services Earnings: Donnelley Financial Solutions (NYSE:DFIN) Earns Top Marks
Via StockStory
Topics Regulatory Compliance
Tickers DFIN PAY
Exposures Legal Regulatory
News headline image
Elser Financial Planning Loads Up on Merchants Bancorp Shares Worth $1.1 Billion ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers MBIN
Exposures Legal Regulatory
News headline image
An Aehr Test Systems Director Sold 8,000 Shares. Here's What That Means for Investors. ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers AEHR
Exposures Legal Regulatory
News headline image
Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers LQDA
Exposures Legal Regulatory
News headline image
UWM Holdings' (UWMC) CEO Sells 2 Million Shares for $7.5 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers UWMC
Exposures Legal Regulatory
News headline image
Dianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000 ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers DNTH
Exposures Legal Regulatory
News headline image
Should You Buy Ethereum Before the Next Crypto Bull Run? ↗
Via The Motley Fool
Topics Artificial Intelligence Bonds Regulatory Compliance
Exposures Artificial Intelligence Debt Markets Legal
News headline image
An Insider at The Buckle Sold 30,000 Shares Worth $1.6 Million ↗
Via The Motley Fool
Topics Credit Cards Regulatory Compliance
Tickers BKE
Exposures Interest Rates Legal Regulatory
News headline image
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers ADPT
Exposures COVID-19 Legal Regulatory
News headline image
The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock? ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers MLTX
Exposures Legal Regulatory
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.